Nobiletin Exhibits Neuroprotective Effects against Mitochondrial Complex I Inhibition via Regulating Apoptotic Signaling

다국어 초록 (Multilingual Abstract)

Nobiletin, a polymethoxylated flavonoid found in citrus, has been studied because of its modulatory functions in cellular signaling cascades, and effects to prevent mitochondrial calcium overload and neuronal cell death. Particularly, we previously reported that nobiletin induced changes in the mitochondrial membrane potential through K+ channel regulation, suggesting that nobiletin might exert neuroprotective effects via regulating mitochondrial functions associated with the electron transport chain (ETC) system. This study investigated whether nobiletin regulated mitochondrial dysfunction mediated by ETC system downregulation by inhibiting complex I (CI) and complex III (CIII) in pure mitochondria and the cortical neurons of rats. The results showed that nobiletin significantly reduced mitochondrial reactive oxygen species (ROS) production, inhibited apoptotic signaling, enhanced ATP production and then restored neuronal viability under conditions of CI inhibition, but not CIII inhibition.
These effects were attributed to the downregulation of translocation of apoptosis-induced factor (AIF), and the upregulation of CI activity and the expression of antioxidant enzymes such as Nrf2 and HO-1. Together with our previous study, these results indicate that the neuroprotective effects of nobiletin under mitochondrial dysfunction may be associated with its function to activate antioxidant signaling cascades. Our findings suggest the possibility that nobiletin has therapeutic potential in treating oxidative neurological and neurodegenerative diseases mediated by mitochondrial dysfunction.

참고문헌 (Reference)

1 Li H, "Water-soluble coenzyme q10 inhibits nuclear translocation of apoptosis inducing factor and cell death caused by mitochondrial complex I inhibition" 15 : 13388-133400, 2014

2 Turrens JF, "Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria" 237 : 408-414, 1985

3 Akopova OV, "The use of dichlorofluorescein as a probe for monitoring the effects of calcium on ROS production in mitochondria" 6 : 3-, 2017

4 Brand MD, "The sites and topology of mitochondrial superoxide production" 45 : 466-472, 2010

5 Ghezzi P, "The oxidative stress theory of disease : levels of evidence and epistemological aspects" 174 : 1784-1796, 2017

6 Huang H, "The multifunctional effects of nobiletin and its metabolites in vivo and in vitro" 2016 : 2918796-, 2016

7 Lenaz G, "The mitochondrial production of reactive oxygen species : mechanisms and implications in human pathology" 52 : 159-164, 2001

8 Nguyen T, "The Nrf2-antioxidant response element signaling pathway and its activation by oxidative stress" 284 : 13291-13295, 2009

9 Turrens JF, "Superoxide production by the mitochondrial respiratory chain" 17 : 3-8, 1997

10 Rezaiean Mehrabadi A, "Study of the effects of ATP suppliers and thiol reductants on toxicity of pioglitazone in isolated rat liver mitochondria" 14 : 825-832, 2015

11 Kishida KT, "Sources and targets of reactive oxygen species in synaptic plasticity and memory" 9 : 233-244, 2007

12 Dallner G, "Regulation of ubiquinone metabolism" 29 : 285-294, 2000

13 Circu ML, "Reactive oxygen species, cellular redox systems, and apoptosis" 48 : 749-762, 2010

14 He X, "Protection against chromium(VI)-induced oxidative stress and apoptosis by Nrf2. Recruiting Nrf2 into the nucleus and disrupting the nuclear Nrf2/Keap1 association" 98 : 298-309, 2007

15 Wei MC, "Proapoptotic BAX and BAK : a requisite gateway to mitochondrial dysfunction and death" 292 : 727-730, 2001

16 Khan NM, "Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6KP90RSK signaling axis" 116 : 159-171, 2018

17 Paladino S, "Nrf2 pathway in age-related neurological disorders : insights into microRNAs" 47 : 1951-1976, 2018

18 Khan MN, "Nrf2 inhibits apoptosis and suppresses oxidative stress by activating NOX4/ERK1/2/ELK1 signaling axis in human chondrocytes" 69 (69): 55-, 2017

19 Onozuka H, "Nobiletin, a citrus flavonoid, improves memory impairment and Abeta pathology in a transgenic mouse model of Alzheimer's disease" 326 : 739-744, 2008

20 Yabuki Y, "Nobiletin treatment improves motor and cognitive deficits seen in MPTP-induced Parkinson model mice" 259 : 126-141, 2014

21 Jojua N, "Nobiletin restores impaired hippocampal mitochondrial bioenergetics in hypothyroidism through activation of matrix substrate-level phosphorylation" 18 : 225-231, 2015

22 Yamamoto Y, "Nobiletin improves brain ischemiainduced learning and memory deficits through stimulation of CaMKII and CREB phosphorylation" 1295 : 218-229, 2009

23 Choi SY, "Nobiletin from citrus fruit peel inhibits the DNA-binding activity of NF-kappaB and ROS production in LPS-activated RAW 264. 7 cells" 113 : 149-155, 2007

24 이지형, "Nobiletin attenuates neurotoxic mitochondrial calcium overload through K+ influx and ΔΨm across mitochondrial inner membrane" 대한약리학회 22 (22): 311-319, 2018

25 Puntel RL, "Mitochondrial dysfunction induced by different organochalchogens is mediated by thiol oxidation and is not dependent of the classical mitochondrial permeability transition pore opening" 117 : 133-143, 2010

26 Rego AC, "Mitochondrial dysfunction and reactive oxygen species in excitotoxicity and apoptosis : implications for the pathogenesis of neurodegenerative diseases" 28 : 1563-1574, 2003

27 Bhatti JS, "Mitochondrial dysfunction and oxidative stress in metabolic disorders-a step towards mitochondria based therapeutic strategies" 1863 : 1066-1077, 2017

28 Grimm A, "Mitochondrial dysfunction : the missing link between aging and sporadic Alzheimer’s disease" 17 : 281-296, 2016

29 Guzy RD, "Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing" 1 : 401-408, 2005

30 Gonzalez-Halphen D, "Mitochondrial complex I and cell death : a semi-automatic shotgun model" 2 : e222-, 2011

31 Martínez-Reyes I, "Mitochondrial TCA cycle metabolites control physiology and disease" 11 : 102-, 2020

32 Smaili SS, "Mitochondria, calcium and pro-apoptotic proteins as mediators in cell death signaling" 36 : 183-190, 2003

33 Conley KE, "Mitochondria to motion: optimizing oxidative phosphorylation to improve exercise performance" 219 (219): 243-249, 2016

34 Murphy AN, "Mitochondria in neurodegeneration : bioenergetic function in cell life and death" 19 : 231-245, 1999

35 Giampazolias E, "Mitochondria and the hallmarks of cancer" 283 : 803-814, 2016

36 Barja G, "Localization at complex I and mechanism of the higher free radical production of brain nonsynaptic mitochondria in the short-lived rat than in the longevous pigeon" 30 : 235-243, 1998

37 Veto S, "Inhibiting poly(ADP-ribose) polymerase: a potential therapy against oligodendrocyte death" 133 (133): 822-834, 2010

38 Fato R, "Generation of reactive oxygen species by mitochondrial complex I : implications in neurodegeneration" 33 : 2487-2501, 2008

39 Kaminskyy VO, "Free radicals in cross talk between autophagy and apoptosis" 21 : 86-102, 2014

40 Kehrer JP, "Free radicals and related reactive species as mediators of tissue injury and disease : implications for health" 45 : 765-798, 2015

41 Kuka S, "Effect of aging on formation of reactive oxygen species by mitochondria of rat heart" 32 : 415-420, 2013

42 García-Ruiz C, "Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione" 272 : 11369-11377, 1997

43 Tominaga H, "Different effects of palmitoyl-L-carnitine and palmitoyl-CoA on mitochondrial function in rat ventricular myocytes" 295 : H105-H112, 2008

44 Saki M, "DNA damage related crosstalk between the nucleus and mitochondria" 107 : 216-227, 2017

45 Czabotar PE, "Control of apoptosis by the BCL-2 protein family : implications for physiology and therapy" 15 : 49-63, 2014

46 Muller FL, "Complex III releases superoxide to both sides of the inner mitochondrial membrane" 279 : 49064-49073, 2004

47 Greenamyre JT, "Complex I and Parkinson’s disease" 52 : 135-141, 2001

48 Licht-Mayer S, "Cell type-specific Nrf2 expression in multiple sclerosis lesions" 130 : 263-277, 2015

49 Ibáñez P, "Causal relation between alpha-synuclein gene duplication and familial Parkinson’s disease" 364 : 1169-1171, 2004

50 Segawa K, "Caspase-mediated cleavage of phospholipid flippase for apoptotic phosphatidylserine exposure" 344 : 1164-1168, 2014

51 Bano D, "Apoptosis-inducing factor(AIF)in physiology and disease : the tale of a repented natural born killer" 30 : 29-37, 2018

52 Sevrioukova IF, "Apoptosis-inducing factor : structure, function, and redox regulation" 14 : 2545-2579, 2011

53 Piskernik C, "Antimycin A and lipopolysaccharide cause the leakage of superoxide radicals from rat liver mitochondria" 1782 : 280-285, 2008

54 Jeong JY, "Activation of the Nrf2/HO-1 signaling pathway contributes to the protective effects of baicalein against oxidative stress-induced DNA damage and apoptosis in HEI193 Schwann cells" 16 : 145-155, 2019

55 Iglesias-González J, "A simple method for isolating rat brain mitochondria with high metabolic activity : effects of EDTA and EGTA" 213 : 39-42, 2013

56 Indo HP, "A mitochondrial superoxide theory for oxidative stress diseases and aging" 56 : 1-7, 2015

57 Alzheimer’s Association, "2016 Alzheimer’s disease facts and figures" 12 : 459-509, 2016

58 Kim JW, "15-Deoxy-Delta(12, 14)-prostaglandin J(2)rescues PC12 cells from H2O2-induced apoptosis through Nrf2-mediated upregulation of heme oxygenase-1 : potential roles of Akt and ERK1/2" 76 : 1577-1589, 2008